Shukra Pharmaceuticals Ltd — Important, 14-08-2026: Company Update

Shukra Pharmaceuticals Limited has achieved a significant milestone with the direct listing of its equity shares on the National Stock Exchange (NSE). Trading on NSE will commence, while shares will continue to trade on the Bombay Stock Exchange (BSE). This dual-listing strategy aims to enhance the company's visibility, attract a wider range of institutional and retail investors, and deepen market liquidity. This move reflects the company's strong financial health and operational growth, offering new investors a more accessible platform and demonstrating a commitment to driving long-term shareholder value.